Sep 29, 2026 08:30AM
Jul 3, 2026 06:10PM
Jun 26, 2026 06:29PM
Mar 30, 2026 07:19AM
Feb 18, 2026 07:19AM
Feb 18, 2026 07:19AM
Feb 12, 2026 06:15PM Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026
Dec 18, 2025 07:31AM
Dec 18, 2025 07:31AM
Nov 13, 2025 05:21PM
Nov 5, 2025 07:16AM
Nov 5, 2025 07:16AM
Oct 22, 2025 07:20AM
Oct 1, 2025 07:17AM NIAID awards Appili and Vitalex up to $40M for fungal vaccine development
Oct 1, 2025 07:17AM
Sep 23, 2025 05:02PM
Sep 23, 2025 05:01PM
Sep 9, 2025 07:20AM
Aug 14, 2025 05:05PM
Jun 25, 2025 06:04PM
May 20, 2025 10:17AM Saptalis Pharmaceuticals Announces the Launch of LIKMEZ® — The First and Only US FDA-Approved Ready-to-Use Oral Suspension of Metronidazole
Apr 28, 2025 07:41AM
Apr 14, 2025 08:15AM
Apr 14, 2025 08:15AM
Apr 2, 2025 08:17AM
Apr 2, 2025 08:15AM
Mar 24, 2025 08:15AM
Mar 18, 2025 07:22AM Appili Therapeutics Announces Submission of U.S. Federal Government Funding Proposals and Provides Corporate and Aditxt Transaction Update
Mar 17, 2025 08:15AM
Mar 6, 2025 08:15AM
Mar 6, 2025 08:15AM
Feb 14, 2025 05:06PM
Nov 14, 2024 07:15AM
Nov 7, 2024 08:30AM
Nov 6, 2024 08:30AM Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary Adifem
Oct 31, 2024 08:30AM
Oct 28, 2024 08:15AM
Oct 21, 2024 08:15AM
Oct 17, 2024 07:15AM
Oct 10, 2024 08:15AM
Oct 10, 2024 07:13AM
Oct 8, 2024 08:15AM Aditxt Completes Third Parent Equity Investment Under Amended and Restated Merger Agreement With Evofem
Oct 3, 2024 08:15AM
Sep 24, 2024 08:15AM
Sep 20, 2024 08:15AM
Sep 17, 2024 05:11PM
Sep 9, 2024 08:15AM
Aug 13, 2024 05:19PM
Jul 25, 2024 08:30AM Aditxt Signs Second Amendment to the Arrangement Agreement with Appili Therapeutics, Targeting September 30 Closing of the Acquisition
Jun 25, 2024 05:46PM

335,069 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All